Literature DB >> 11483279

Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery.

Y K Oh1, J P Kim, T S Hwang, J J Ko, J M Kim, J S Yang, C K Kim.   

Abstract

Nasal administration is emerging as a new route of DNA vaccine delivery. We aimed to study the extent of absorption and biodistribution of intranasally administered plasmid DNA. After intranasal administration, the level of plasmid DNA in the serum peaked at 1.5 h. The ratio of the area under the concentration (AUC) after intranasal administration of DNA over the AUC after intravenous administration was 0.14. At 15 min post inoculation, the highest organ distribution was observed in the liver and the cervical lymph nodes showed the highest level among the lymph nodes. At 24 h a higher localization of plasmids to the brain than to the lung and spleen was notable. A significant level of mRNA expression was observed in the lymph nodes. These results suggest that plasmid DNA can be substantially absorbed and distributed to the lymph nodes after intranasal administration, partly explaining the systemic immunogenicity of intranasally administered plasmid DNA vaccines.

Mesh:

Substances:

Year:  2001        PMID: 11483279     DOI: 10.1016/s0264-410x(01)00188-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy.

Authors:  In-Kwon Han; Mi Young Kim; Hyang-Min Byun; Tae Sun Hwang; Jung Mogg Kim; Kwang Woo Hwang; Tae Gwan Park; Woon-Won Jung; Taehoon Chun; Gil-Jae Jeong; Yu-Kyoung Oh
Journal:  J Mol Med (Berl)       Date:  2006-11-07       Impact factor: 4.599

2.  Intranasal drug delivery: a novel approach.

Authors:  Yashpal Chugh; Pragati Kapoor; A K Kapoor
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-04-25

3.  Distribution and expression of recombinant plasmid encoding chicken interleukin-2.

Authors:  Z Q You; L Yu; C Z Zhang; L Li; M J Lu; Z J Mao; Y Liu; W Y Chu
Journal:  Vet Res Commun       Date:  2006-12-20       Impact factor: 2.459

4.  Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.

Authors:  Eduardo Fonseca Pinto; Roberta Olmo Pinheiro; Alice Rayol; Vicente Larraga; Bartira Rossi-Bergmann
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

5.  Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis.

Authors:  Peter Klucar; Peter F Barnes; Ying Kong; Susan T Howard; Xiuhua Pang; Fang-Fang Huang; Amy R Tvinnereim; Buka Samten; Homayoun Shams
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

6.  Nanotechnology for CNS delivery of bio-therapeutic agents.

Authors:  Lipa Shah; Sunita Yadav; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

7.  Evaluation of pharmacokinetics of bioreducible gene delivery vectors by real-time PCR.

Authors:  Qing-Hui Zhou; Chao Wu; Devika Soundara Manickam; David Oupický
Journal:  Pharm Res       Date:  2009-02-25       Impact factor: 4.200

8.  Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery.

Authors:  A A M Coelho-Castelo; A P Trombone; R S Rosada; R R Santos; V L D Bonato; A Sartori; C L Silva
Journal:  Genet Vaccines Ther       Date:  2006-01-30

9.  Live bacterial vaccines--a review and identification of potential hazards.

Authors:  Ann Detmer; Jacob Glenting
Journal:  Microb Cell Fact       Date:  2006-06-23       Impact factor: 5.328

10.  Streptococcus pneumoniae Endopeptidase O Promotes the Clearance of Staphylococcus aureus and Streptococcus pneumoniae via SH2 Domain-Containing Inositol Phosphatase 1-Mediated Complement Receptor 3 Upregulation.

Authors:  Sijie Li; Hong Zhang; Jiangming Xiao; Taixian Yuan; Zhaoche Shu; Yajun Min; Wenchun Xu; Yibing Yin; Xuemei Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-07-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.